Menu Menu

TLSIW    Trisalus Life Sciences Inc    1826667    
Income Statement
Revenue 7,349,000
Net Income -2,399,000
Profit Margin -32.64%

Balance Sheet
Current Assets 23,808,000
Assets 27,477,000
Current Liabilities 9,918,000
Liabilities 47,911,000
Equity -20,434,000

Cash Flow Statement
Operating Cash Flow -35,136,000
Investing Cash Flow -295,000

Market Analysis
Market Cap 138,936,503
Price 1.21
BVPS 14.51
PB 0.08
PS 4.73
FCF -35,431,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view TLSIW documents filed with the SEC.


TLSIW Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: